Status:
COMPLETED
Vaccination Education Through Pharmacists and Senior Centers (VEPSC)
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Thomas Jefferson University
Conditions:
Infectious Disease
Pneumonia, Bacterial
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The study consists of two arms (PHARM and PEER) designed to educate participants about three vaccine-preventable diseases (zoster, pneumonia, and influenza) and vaccination. PHARM will consist of a 60...
Detailed Description
In the pharmacist-led ("PHARM") intervention group, participants will be given a 60-minute formal didactic presentation on vaccine-preventable diseases and vaccination. This presentation will be desig...
Eligibility Criteria
Inclusion
- Age ≥50;
- Can attend a 2-hour session (though both PHARM and PEER entail 60 minutes of intervention, an additional hour is needed to allow for informed consent and data collection);
- Speak and read English at ≥4th grade level as determined by a brief reading passage;
- Cognitively intact as evidenced by an Abbreviated Mental Status Test score ≥7.
Exclusion
- Failure to meet inclusion criteria
- Failure to give informed consent to participate in the study
Key Trial Info
Start Date :
October 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2019
Estimated Enrollment :
335 Patients enrolled
Trial Details
Trial ID
NCT03239665
Start Date
October 10 2017
End Date
August 31 2019
Last Update
July 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers University
Piscataway, New Jersey, United States, 08854